BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19711425)

  • 1. The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers.
    Schüngel S; Buitrago-Molina LE; Nalapareddy Pd; Lebofsky M; Manns MP; Jaeschke H; Gross A; Vogel A
    Hepatology; 2009 Nov; 50(5):1558-66. PubMed ID: 19711425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switch from type II to I Fas/CD95 death signaling on in vitro culturing of primary hepatocytes.
    Walter D; Schmich K; Vogel S; Pick R; Kaufmann T; Hochmuth FC; Haber A; Neubert K; McNelly S; von Weizsäcker F; Merfort I; Maurer U; Strasser A; Borner C
    Hepatology; 2008 Dec; 48(6):1942-53. PubMed ID: 19003879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of inflammation and apoptosis in Fas-resistant hepatocyte-specific Bid-deficient mice.
    Lazic M; Eguchi A; Berk MP; Povero D; Papouchado B; Mulya A; Johnson CD; Feldstein AE
    J Hepatol; 2014 Jul; 61(1):107-15. PubMed ID: 24681344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase-3 feeds back on caspase-8, Bid and XIAP in type I Fas signaling in primary mouse hepatocytes.
    Ferreira KS; Kreutz C; Macnelly S; Neubert K; Haber A; Bogyo M; Timmer J; Borner C
    Apoptosis; 2012 May; 17(5):503-15. PubMed ID: 22246639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed-onset caspase-dependent massive hepatocyte apoptosis upon Fas activation in Bak/Bax-deficient mice.
    Hikita H; Takehara T; Kodama T; Shimizu S; Shigekawa M; Hosui A; Miyagi T; Tatsumi T; Ishida H; Li W; Kanto T; Hiramatsu N; Shimizu S; Tsujimoto Y; Hayashi N
    Hepatology; 2011 Jul; 54(1):240-51. PubMed ID: 21425311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XIAP discriminates between type I and type II FAS-induced apoptosis.
    Jost PJ; Grabow S; Gray D; McKenzie MD; Nachbur U; Huang DC; Bouillet P; Thomas HE; Borner C; Silke J; Strasser A; Kaufmann T
    Nature; 2009 Aug; 460(7258):1035-9. PubMed ID: 19626005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse genetic background contributes to hepatocyte susceptibility to Fas-mediated apoptosis.
    Weerasinghe SV; Park MJ; Portney DA; Omary MB
    Mol Biol Cell; 2016 Oct; 27(20):3005-3012. PubMed ID: 27535425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-tyrosine phosphatase 1B deficiency protects against Fas-induced hepatic failure.
    Sangwan V; Paliouras GN; Cheng A; Dubé N; Tremblay ML; Park M
    J Biol Chem; 2006 Jan; 281(1):221-8. PubMed ID: 16234234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis.
    Li S; Zhao Y; He X; Kim TH; Kuharsky DK; Rabinowich H; Chen J; Du C; Yin XM
    J Biol Chem; 2002 Jul; 277(30):26912-20. PubMed ID: 12011074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases.
    Vogel A; Aslan JE; Willenbring H; Klein C; Finegold M; Mount H; Thomas G; Grompe M
    Gastroenterology; 2006 Jan; 130(1):104-19. PubMed ID: 16401474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
    Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
    Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor α sensitizes primary murine hepatocytes to Fas/CD95-induced apoptosis in a Bim- and Bid-dependent manner.
    Schmich K; Schlatter R; Corazza N; Sá Ferreira K; Ederer M; Brunner T; Borner C; Merfort I
    Hepatology; 2011 Jan; 53(1):282-92. PubMed ID: 20872776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways.
    Conway EM; Pollefeyt S; Steiner-Mosonyi M; Luo W; Devriese A; Lupu F; Bono F; Leducq N; Dol F; Schaeffer P; Collen D; Herbert JM
    Gastroenterology; 2002 Aug; 123(2):619-31. PubMed ID: 12145814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of BID Delays FASL-Induced Cell Death of Mouse Neutrophils and Aggravates DSS-Induced Weight Loss.
    Wicki S; Gurzeler U; Corazza N; Genitsch V; Wong WW; Kaufmann T
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis.
    Nalapareddy Pd; Schüngel S; Hong JY; Manns MP; Jaeschke H; Vogel A
    Am J Pathol; 2009 Sep; 175(3):1077-85. PubMed ID: 19661444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human islet cells are killed by BID-independent mechanisms in response to FAS ligand.
    Joglekar MV; Trivedi PM; Kay TW; Hawthorne WJ; O'Connell PJ; Jenkins AJ; Hardikar AA; Thomas HE
    Apoptosis; 2016 Apr; 21(4):379-89. PubMed ID: 26758067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis.
    Yin XM; Wang K; Gross A; Zhao Y; Zinkel S; Klocke B; Roth KA; Korsmeyer SJ
    Nature; 1999 Aug; 400(6747):886-91. PubMed ID: 10476969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury.
    Higuchi H; Miyoshi H; Bronk SF; Zhang H; Dean N; Gores GJ
    J Pharmacol Exp Ther; 2001 Dec; 299(3):866-73. PubMed ID: 11714870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in FADD levels, distribution, and phosphorylation in TNFalpha-induced apoptosis in hepatocytes is caspase-3, caspase-8 and BID dependent.
    Zhang X; Vallabhaneni R; Loughran PA; Shapiro R; Yin XM; Yuan Y; Billiar TR
    Apoptosis; 2008 Aug; 13(8):983-92. PubMed ID: 18543108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNFα sensitizes hepatocytes to FasL-induced apoptosis by NFκB-mediated Fas upregulation.
    Faletti L; Peintner L; Neumann S; Sandler S; Grabinger T; Mac Nelly S; Merfort I; Huang CH; Tschaharganeh D; Kang TW; Heinzmann F; D'Artista L; Maurer U; Brunner T; Lowe S; Zender L; Borner C
    Cell Death Dis; 2018 Sep; 9(9):909. PubMed ID: 30185788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.